Skip to main content
Reshma Mahtani, DO, Oncology, Miami, FL

Reshma L Mahtani DO

Breast Cancer


Chief of Breast Medical Oncology, Baptist Health's Miami Cancer Institute

Request Appointment
  • Baptist Health Miami Cancer Institute8900 N Kendall DrMiami, FL 33176

  • Book by Phone+1(516) 973-4192

Overview of  Dr. Mahtani

Dr. Reshma Mahtani is an oncologist in Miami, FL and is affiliated with multiple hospitals in the area, including Baptist Hospital of Miami and University of Miami Hospital. She received her medical degree from University of New England College of Osteopathic Medicine and has been in practice 16 years. Dr. Mahtani accepts several types of health insurance, listed below. She is one of 64 doctors at University of Miami Hospital and one of 66 doctors at Baptist Hospital of Miami who specialize in Oncology. She has more than 60 publications and over 500 citings.

Education & Training

  • Westchester Medical Center
    Westchester Medical CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
  • Westchester Medical Center
    Westchester Medical CenterResidency, Internal Medicine, 2002 - 2004
  • Greenwich Hospital/Yale University
    Greenwich Hospital/Yale UniversityInternship, Internal Medicine, 2001 - 2002
  • University of New England College of Osteopathic Medicine
    University of New England College of Osteopathic MedicineClass of 2001

Certifications & Licensure

  • FL State Medical License
    FL State License 2007 - 2026
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2017
  • CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2013-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy with Disease Recurrence in Patients with Triple-Negative Breast Cancer  
    Rita Nanda, Carla Falkson, Filipa C Lynce, Claudine Isaacs, Marcelo Blaya, Elisavet Paplomata, Radhika Walling, Reshma Mahtani, Tarah J Ballinger, Kathy D Miller, Brya..., JAMA Oncology

Authored Content

  • Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy with Disease Recurrence in Patients with Triple-Negative Breast CancerJuly 2020

Press Mentions

  • Back-to-Back Sessions to Illuminate ADC Complexities, Considerations for Clinical Use
    Back-to-Back Sessions to Illuminate ADC Complexities, Considerations for Clinical UseDecember 10th, 2025
  • Miami Cancer Institute Presents Latest Research at ASCO Meeting
    Miami Cancer Institute Presents Latest Research at ASCO MeetingJune 4th, 2025
  • Agendia to Unveil Novel Data on Genomic Risk and Treatment Disparities in Early-Stage Breast Cancer at 2025 ASCO® Annual Meeting
    Agendia to Unveil Novel Data on Genomic Risk and Treatment Disparities in Early-Stage Breast Cancer at 2025 ASCO® Annual MeetingMay 15th, 2025

Professional Memberships

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    AvMed Health Open Access
    BCBS Blue Card PPO
    BCBS Florida BlueCare HMO
    BCBS Florida NetworkBlue
    BCBS Florida Preferred Patient Care PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Coventry Florida - Employer Group PPO
    First Health PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    United - River Valley Neighborhood Health Partnership
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: